Evidence map›Paper›PMID 16611414›Full record

ArticleNeoplasia (New York, N.Y.)2006

Noninvasive MRI of endothelial cell response to human breast cancer cells.

Barjor Gimi, Noriko Mori, Ellen Ackerstaff, Emma E Frost, Jeff W M Bulte, Zaver M Bhujwalla

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. MRI of metastasis-permissive microenvironments.Future oncology (London, England) · 2011
    Review
  4. Article
  5. Neoplasia: the second decade.Neoplasia (New York, N.Y.) · 2008
    Article
  6. Molecular imaging of metastatic potential.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2008
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Barjor GimiThe Johns Hopkins University In Vivo Cellular and Molecular Imaging Program, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Noriko Mori
Ellen Ackerstaff
Emma E Frost
Jeff W M Bulte
Zaver M Bhujwalla
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Theranostic Imaging of Metastatic Prostate CancerP50CA103175 · NCI · JOHNS HOPKINS UNIVERSITY · PI BHUJWALLA, ZAVER M. · 2003 to 2015
$17.9M
HOSTILE ENVIRONMENTS PROMOTE INVASION AND METATASISR01CA082337 · NCI · JOHNS HOPKINS UNIVERSITY · PI BHUJWALLA, ZAVER M. · 1999 to 2024
$5.1M
MR Tracking of Magnetically Labeled Stem Cells in CNSR01NS045062 · NINDS · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W. · 2003 to 2013
$4.4M
NCI NIH HHS 1P50 CA 103175NCI NIH HHS 2R01 CA82337NCI NIH HHS P50 CA103175NCI NIH HHS R01 CA082337NINDS NIH HHS 1R01 NS045062NINDS NIH HHS R01 NS045062
6 · The paper itself

Abstract

We have developed a noninvasive magnetic resonance imaging (MRI) assay to characterize human umbilical vein endothelial cell (HUVEC) motility, invasion, and network formation in response to the presence of cancer cells. HUVECs were labeled with a superparamagnetic iron oxide T(2) contrast agent and cocultured with MDA-MB-231 breast cancer cells in the presence of an extracellular matrix (ECM) gel. Invasion into the ECM gel by HUVECs in response to paracrine factors secreted by MDA-MB-231 cancer cells, as well as network formation by HUVECs, was easily tracked with MRI. The invasive behavior of HUVECs was not observed in the absence of cancer cells. This noninvasive assay used to characterize the response of endothelial cells (ECs) can be used to understand the role of proangiogenic or antiangiogenic stimuli, and to study the interactions between ECs and other disease-specific cells in pathologies with aberrant angiogenesis, such as retinopathy and arthritis.

Indexed as

AdenocarcinomaAngiogenic ProteinsBreast NeoplasmsCell Line, TumorCell MovementCoculture TechniquesContrast MediaDextransEndothelial CellsEndothelium, VascularExtracellular MatrixFemaleFerrosoferric OxideGelsGrowth SubstancesHumansAngiogenic ProteinsContrast MediaDextransFerrosoferric OxideferumoxidesGelsGrowth SubstancesIronMagnetite NanoparticlesNeoplasm ProteinsOxidesPolylysine

Identifiers

PMID16611414
PMCPMC1578524
OpenAlexW2091092851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.